Estrella Immunopharma (ESLA) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Estrella Immunopharma, Inc. announced that its board of directors has approved a share repurchase program up to $1 million of its common stock. The repurchase is not an obligation and will depend on future market conditions and other factors, with details to be decided as those conditions evolve.
For further insights into ESLA stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue